View Exam | PowerPak

1. According to the American Association of Clinical Endocrinology, which of the following is the correct definition of obesity?

A. A complex, adiposity-based chronic disease arising from individual behavior and lifestyle choices (eg, poor diet and lack of exercise) B. A complex, adiposity-based chronic disease, with interacting genetic, environmental, and behavioral determinants C. A body mass index (BMI) of ≥ 30 with ≥ 1 other weight-related comorbidity (eg, hypertension, types 2 diabetes [T2D], dyslipidemia) D. A BMI of ≥ 35 with ≥ 1 other weight-related comorbidity (eg, hypertension, T2D, dyslipidemia)

2. Which of the following is the correct starting dose of phentermine/topiramate?

A. 3.75/23 mg B. 7.5/46 mg C. 11.25/69 mg D. 15/19 mg

3. If, after 16 weeks, a patient taking liraglutide titrated to 3.0 mg loses 3.5% of baseline body weight, what is the most appropriate recommendation?

A. Continue the drug and reassess after 3 months B. Continue the drug and add another obesity pharmacotherapy with a different mechanism of action C. Discontinue the drug and do not switch to an alternative obesity pharmacotherapy D. Discontinue the drug and switch to an alternative obesity pharmacotherapy

4. Which obesity medication does not require any dose titration?

A. Liraglutide 3.0 mg B. Orlistat C. Naltrexone/bupropion D. Phentermine/topiramate

5. Which of the following is a contraindication for naltrexone/bupropion?

A. T2D B. Renal impairment C. Uncontrolled hypertension D. Psoriasis

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. According to the American Association of Clinical Endocrinology, which of the following is the correct definition of obesity?

2. Which of the following is the correct starting dose of phentermine/topiramate?

3. If, after 16 weeks, a patient taking liraglutide titrated to 3.0 mg loses 3.5% of baseline body weight, what is the most appropriate recommendation?

4. Which obesity medication does not require any dose titration?

5. Which of the following is a contraindication for naltrexone/bupropion?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. According to the American Association of Clinical Endocrinology, which of the following is the correct definition of obesity?

2. Which of the following is the correct starting dose of phentermine/topiramate?

3. If, after 16 weeks, a patient taking liraglutide titrated to 3.0 mg loses 3.5% of baseline body weight, what is the most appropriate recommendation?

4. Which obesity medication does not require any dose titration?

5. Which of the following is a contraindication for naltrexone/bupropion?

« Return to Activity

Customers who Purchased
this Activity also Purchased